Sana Biotechnology, Inc. (SANA) Tops Q3 EPS by 1c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Benchmark Reiterates Buy Rating on The Trade Desk (TTD)
• Goldman Sachs is bullish on these customer experience software stocks